You must log in to view this page.

Sangamo Therapeutics Inc. – Filings and Transcripts

OTC: SGMO
Share price (6/23/26): $0.07
Market cap (6/23/26): $30.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Ownership Filter

Davis Gregory D

Dubois-Stringfellow Nathalie

Willoughby Scott B.

News Filter

Financial Statements or Exhibits

Material Definitive Agreement, Bankruptcy or Receivership, New Financial Obligation or Off-Balance Sheet Arrangement, Cost of Exit or Disposal Activities

Reports Recent Business Highlights and First Quarter 2026 Financial Results

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission